Shepard Jessica G, Airee Anita, Dake Andrew W, McFarland M Shawn, Vora Amit
From the University of Tennessee Health Science Center College of Pharmacy, Knoxville Campus, Department of Endocrinology, Medical University of South Carolina, VA Tennessee Valley Health System, and Endocrinology Consultants of East Tennessee.
South Med J. 2015 Dec;108(12):724-9. doi: 10.14423/SMJ.0000000000000381.
Hemoglobin A1c is the measurement of glycated hemoglobin and can aid in both the diagnosis and continued management of diabetes mellitus. Accurate glycosylated hemoglobin A1c (A1c) measurements are an essential part of decision making in the diagnosis and treatment of type 2 diabetes mellitus. Although national standards exist to eliminate technical error with A1c testing, multiple patient conditions can falsely decrease or elevate the A1c. In this review, we discuss the methods to measure A1c and the corresponding conditions that can affect the clinical utility of the test. Conditions that affect the A1c can be either those that impair erythrocyte production or alter the normal process of glycation. Some variation also has been associated with patient ethnicity and even with normal aging. We describe alternatives to A1c testing for the above clinical scenarios in an effort to make the practicing clinician aware of alternatives for glucose evaluation.
糖化血红蛋白A1c是对糖化血红蛋白的测量,有助于糖尿病的诊断和持续管理。准确的糖化血红蛋白A1c(A1c)测量是2型糖尿病诊断和治疗决策的重要组成部分。尽管存在国家标准以消除A1c检测中的技术误差,但多种患者情况可能会错误地降低或升高A1c。在本综述中,我们讨论了测量A1c的方法以及可能影响该检测临床效用的相应情况。影响A1c的情况可以是损害红细胞生成的情况,也可以是改变正常糖化过程的情况。一些差异还与患者种族甚至正常衰老有关。我们描述了针对上述临床情况的A1c检测替代方法,以使执业临床医生了解葡萄糖评估的替代方法。